Company / Assets per Share
Fulcrum Therapeutics, Inc. Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$5781.45
FY2025
5-year range
$4203.13 / $6645.74
FY2021-FY2025
Trend
+37.5%
vs FY2024
Sector context
#3 of 210
Health Care
What the data says
Among 210 Health Care companies, Fulcrum Therapeutics, Inc. is in the top 1% for assets per share. Assets per Share has fluctuated over the past 8 years, ranging from $4203.13 in FY2023 to $68234.69 in FY2018.
Based on SEC 10-K filings.
5781.45 in FY2025 with a 5-year CAGR of +2.5%. Ranks 3rd among 210 companies in Health Care.
Improved from $4203.13 to $5781.45 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +4.7%
- 5-Year CAGR
- +2.5%
- 10-Year CAGR
- -
Sector benchmark
+1537.1% above sector average
Key checks
Key Insights
- In FY2025, assets per share increased 37.5% year-over-year.
- Ranks #3 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2018.
- Lowest assets per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 8.44 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5781.45 | +37.5% |
| FY2024 | $4206.21 | +0.1% |
| FY2023 | $4203.13 | -16.6% |
| FY2022 | $5038.45 | -24.2% |
| FY2021 | $6645.74 | +30.0% |
| FY2020 | $5110.71 | -48.9% |
| FY2019 | $9998.10 | -85.3% |
| FY2018 | $68234.69 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026